Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician. Initial chapters focus on agents that are considered standard care: *diuretics * ACE inhibitors * angiotensin receptor antagonists * aldosterone antagonists * beta-blockers The discussion moves to agents currently under investigation: *Vasopressin antagonists * erythropoietin Next, the authors consider some controversial drugs: *inotropic agents * antiarrhythmic drugs * anticoagulants An insightful examination of pharmacogenetics considers: *how studies of the genetic profile of patients helps determine which patient populations are most likely to respond to a given class of drugs * the potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum risk Multidrug pharmacy for heart failure therapy An extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.
From the Back Cover
Heart Failure: Pharmacologic Management is the essentialguide for physicians working with these issues to optimise theiruse of pharmacologic therapy for patients with heart failure.This extensively referenced text provides both the biologic andpathologic underpinning for the use of eachpharmacologic agentcurrently recommended, including the clinical investigations thathave led to our understanding of the risks and benefits associatedwith the use of these drugs. In addition, this book reviews severalareas, including vasopressin antagonists, that are under activeinvestigation, but which are expected to prove fruitful in thetherapy of patients with heart failure.
Heart Failure: Pharmacologic Management is written byindividuals with extensive expertise within the field and is theonly text to focus on pharmacologic therapy. It will assist thepractitioner in easily making sense of the extensive number oftreatment agents available and should be considered a vitalcontribution to your bookshelf.
لینک کوتاه : https://bookbaz.ir/?p=2341
نویسنده : Arthur M. Feldman
ناشر : Wiley-Blackwell; 1 edition
سال انتشار : 2007
زبان کتاب : انگلیسی
نوع فایل : PDF
تعداد صفحات : 310
(ISBN) شابک : 1405103612
قیمت کتاب درآمازون : $129.76
حجم فایل : 3 MB